Aspira Pathlab Appoints Company Secretary, Director

Aspira Pathlab & Diagnostics Limited has announced several key appointments following its Board meeting on May 23, 2026. The Board approved the appointment of Mrs. Neetu Maurya as the Company Secretary and Compliance Officer effective May 24, 2026. Additionally, Mr. Vaibhav Odhekar was appointed as an Additional Executive Director for a tenure of five years commencing from May 23, 2026, subject to shareholder approval. The firm M/s. Vishal J Bhanushali & Associates was appointed as the Internal Auditor for the financial year 2026-2027.

Board Appointments

Mrs. Neetu Maurya, an Associate Member of the Institute of Company Secretaries of India, brings comprehensive understanding of company law and corporate compliances. Mr. Vaibhav Odhekar, a seasoned entrepreneur with over 20 years of experience in technology-led platform businesses, joins as Additional Executive Director. He is the Co-founder of POKKT and has held leadership positions at AnyMind Group and Zapak Digital Entertainment Group.

Internal Auditor

M/s. Vishal J Bhanushali & Associates, a firm of Practicing Chartered Accountants (Firm Registration Number: 145806W), has been appointed to conduct the internal audit for a period of one year from April 1, 2026, to March 31, 2027. The firm provides quality auditing, assurance, taxation, and advisory services.

Appointee	Role	Tenure/Effective Date
Mrs. Neetu Maurya	Company Secretary & Compliance Officer	May 24, 2026
Mr. Vaibhav Odhekar	Additional Executive Director	5 years from May 23, 2026
M/s. Vishal J Bhanushali & Associates	Internal Auditor	April 1, 2026 to March 31, 2027

Corporate Governance

The company confirmed that Mr. Vaibhav Odhekar is not debarred from holding the office of Director by virtue of any order from SEBI or other authorities. The disclosures were made pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+5.00%	+27.31%	+111.49%	+108.28%	+145.71%	+333.43%

Aftertrade Broking Private Limited, acting as Manager to the Offer, published a Post-Offer Advertisement on May 18, 2026, in compliance with Regulation 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The advertisement pertains to the concluded open offer for Aspira Pathlab & Diagnostics Limited , a Mumbai-based diagnostics company with CIN L85100MH1973PLC289209.

The open offer was made by five acquirers — Mr. Arvind Karsandas Bhanushali, Mrs. Deepali Arvind Bhanushali, Mr. Jay Arvind Bhanushali, Mr. Nikunj Velji Mange, and Mr. Raj Arvind Bhanushali — along with Mrs. Shraddha Nikunj Mange as the Person Acting in Concert (PAC). The Detailed Public Statement (DPS) for the open offer was published on October 06, 2025, in Financial Express (English), Mumbai Lakshdeep (Marathi), and Jansatta (Hindi).

Offer Structure and Key Dates

The open offer was structured to acquire up to 26,76,180 fully paid-up equity shares of face value ₹10.00/- each, representing 26.00% of the total equity share capital of Aspira Pathlab & Diagnostics Limited, at a price of ₹55/- per share. The key dates for the offer are summarised below.

Parameter:	Details
Offer Opening Date:	Wednesday, 15/04/2026
Offer Closing Date:	Tuesday, 28/04/2026
Date of Payment/Communication of Acceptance/Rejection:	Wednesday, 13/05/2026
Manager to the Offer:	Aftertrade Broking Private Limited
Registrar to the Offer:	Integrated Registry Management Services Private Limited

Details of Acquisition: Proposed vs. Actuals

The open offer received 22,82,507 equity shares against the proposed 26,76,180 equity shares. All 22,82,507 tendered equity shares were in dematerialised form and were validly accepted. The table below presents a comparison of the proposed and actual acquisition details.

Particulars:	Proposed in Letter of Offer	Actuals
Offer Price (in Rs.):	₹55/- (Rupees Fifty-Five Only)	₹55/- (Rupees Fifty-Five Only)
Aggregate Shares Tendered:	26,76,180 Equity Shares	22,82,507 Equity Shares
Aggregate Shares Accepted:	26,76,180 Equity Shares	22,82,507 Equity Shares
Size of the Offer:	₹14,71,89,900/- (Rupees Fourteen Crores Seventy-One Lakhs Eighty-Nine Thousand Nine Hundred Only)	₹12,55,37,885/- (Rupees Twelve Crores Fifty Five Lakhs Thirty Seven Thousand Eight Hundred Eighty Five Only)
Shareholding of Acquirers & PAC before Public Announcement (Number):	24,52,111	24,52,111
Shareholding of Acquirers & PAC before Public Announcement (%):	23.82%	23.82%
Shares via Share Purchase Agreement (SPA) — Number:	0	0
Shares via Share Purchase Agreement (SPA) — %:	0.00%	0.00%
Shares Acquired via Open Offer — Number:	26,76,180	22,82,507
Shares Acquired via Open Offer — %:	26.00%	22.18%
Shares Acquired after DPS — Number:	Nil	Nil
Shares Acquired after DPS — %:	Nil	Nil
Price of Shares Acquired after DPS:	Not Applicable	Not Applicable

Pre- and Post-Offer Shareholding Pattern

The open offer has resulted in a significant change in the shareholding structure of Aspira Pathlab & Diagnostics Limited. The combined stake of the Acquirers and PAC increased from 23.82% to 46.00%, while the existing Promoter/Promoter group (other than the Acquirers and PAC) retained their 0.43% holding. Public shareholding declined from 75.75% to 53.57%.

Shareholder Category:	Pre-Offer No. of Shares	Pre-Offer %	Post-Offer No. of Shares	Post-Offer %
Acquirers and PAC:	24,52,111	23.82%	47,34,618	46.00%
Existing Promoter/Promoter Group (other than Acquirers & PAC):	43,999	0.43%	43,999	0.43%
Public (other than Acquirers & PAC):	77,96,890	75.75%	55,14,383	53.57%

Pre-Offer Shareholding of Individual Acquirers and PAC

Prior to the public announcement, the individual shareholdings of the Acquirers and PAC in Aspira Pathlab & Diagnostics Limited were as follows:

Mr. Arvind Karsandas Bhanushali (Acquirer 1): 8,85,500 equity shares (8.60%)
Mrs. Deepali Arvind Bhanushali (Acquirer 2): 8,85,500 equity shares (8.60%)
Mr. Jay Arvind Bhanushali (Acquirer 3): 2,32,727 equity shares (2.26%)
Mr. Nikunj Velji Mange (Acquirer 4): 2,20,158 equity shares (2.14%)
Mr. Raj Arvind Bhanushali (Acquirer 5): 77,964 equity shares (0.76%)
Mrs. Shraddha Nikunj Mange (PAC): 1,50,262 equity shares (1.46%)

The Acquirers and PAC have accepted full responsibility for the information contained in this Post-Offer Advertisement and for their obligations under the SEBI (SAST) Regulations, 2011. The advertisement has been issued by Aftertrade Broking Private Limited (SEBI Reg. No.: INM000013110) on behalf of the Acquirers and PAC, and is signed by Mr. Jay Arvind Bhanushali (Acquirer 3) dated May 18, 2026, from Mumbai. A copy of this Post-Offer Advertisement is available on the websites of SEBI and BSE Limited. Capitalised terms used in the advertisement carry the same meanings as assigned in the Letter of Offer dated March 30, 2026.